← The Wire
RNACNasdaq
Cartesian Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1453687
Pioneering cell therapy for autoimmune diseases using proprietary mRNA technology
red 8-K · 90d
$279M
Market cap
$9.64
Last close
+2.3%
1D
-3.1%
5D
192K
Volume
Price · last 39 sessions+39.1%
May 4L $5.84 · H $10.18Jun 29
275
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 17, 20268-KReg FD DisclosureJun 9, 20268-KExecutive Change · Material AgreementMay 26, 202610-Q10-QApr 30, 20268-KResults of OperationsApr 30, 2026DEF 14ADEF 14AApr 28, 2026DEFA14ADEFA14AApr 28, 2026SC 13D/ASC 13D/AApr 2, 20268-KExecutive ChangeMar 30, 202610-K10-KMar 9, 20268-KResults of OperationsMar 9, 20268-KReg FD DisclosureJan 9, 20268-KExecutive Change · Code of EthicsDec 18, 20258-KReg FD Disclosure · Company UpdateNov 13, 202510-Q10-QNov 6, 20258-KResults of OperationsNov 6, 20258-KExecutive Change · Bylaw AmendmentOct 30, 20258-KExecutive ChangeOct 21, 20258-KExecutive ChangeOct 8, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KShareholder VoteJun 16, 20258-KCompany UpdateMay 30, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 20258-KExecutive ChangeApr 29, 2025DEF 14ADEF 14AApr 28, 2025DEFA14ADEFA14AApr 28, 20258-KReg FD Disclosure · Company UpdateApr 8, 202510-K10-KMar 13, 20258-KResults of OperationsMar 13, 20258-KReg FD DisclosureMar 3, 20258-KCompany UpdateJan 27, 20258-KReg FD DisclosureJan 13, 20258-KReg FD Disclosure · Company UpdateDec 3, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 20248-KCompany UpdateSep 26, 20248-KShareholder VoteSep 23, 2024S-1/AS-1/ASep 20, 2024S-1/AS-1/ASep 9, 2024DEF 14ADEF 14AAug 16, 2024SC 13GSC 13GAug 12, 202410-Q10-QAug 8, 20248-KResults of Operations · Reg FD DisclosureAug 8, 2024S-1S-1Aug 2, 20248-KExecutive Change · Material AgreementJul 2, 20248-KExecutive Change · Shareholder VoteJun 17, 20248-KReg FD Disclosure · Company UpdateMay 22, 202410-Q10-QMay 8, 20248-KResults of Operations · Reg FD DisclosureMay 8, 2024DEF 14ADEF 14AApr 26, 2024DEFA14ADEFA14AApr 26, 20248-KCompany UpdateApr 22, 20248-KReg FD Disclosure · Company UpdateApr 9, 20248-KExecutive ChangeApr 1, 20248-KBylaw Amendment · Shareholder VoteMar 28, 20248-KAgreement TerminatedMar 14, 202410-K10-KMar 7, 20248-KResults of OperationsMar 7, 20248-KExecutive Change · Material AgreementMar 5, 2024DEFA14ADEFA14AFeb 14, 2024DEF 14ADEF 14AFeb 14, 2024SC 13GSC 13GFeb 9, 20248-K/ACompany UpdateJan 23, 20248-KDelisting NoticeJan 19, 20248-KReg FD DisclosureJan 8, 20248-KExecutive ChangeNov 27, 2023SC 13DSC 13DNov 22, 2023SC 13DSC 13DNov 22, 202310-Q10-QNov 13, 2023DEFA14ADEFA14ANov 13, 20238-KExecutive Change · Material AgreementNov 13, 20238-KExecutive Change · Material AgreementOct 31, 20238-KExecutive ChangeSep 25, 20238-KCompany UpdateSep 13, 202310-Q10-QAug 17, 20238-KResults of OperationsAug 17, 20238-KShareholder VoteJun 16, 2023DEFA14ADEFA14AJun 13, 2023
Insider Activity
In the 90 days to Jan 6, 2026: 1 insider bought $206K · 3 sold $259K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 6, 2026 | Brunn CarstenPresident and CEO | Sell | 23,766 | $6.82 | $162K |
| Jan 6, 2026 | Davis BlaineChief Financial Officer | Sell | 10,591 | $6.82 | $72K |
| Jan 6, 2026 | Miljkovic MilosChief Medical Officer | Sell | 3,573 | $6.82 | $24K |
| Dec 4, 2025 | Barabe Timothy CDirector | Buy | 30,000 | $6.86 | $206K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance